Cargando…
UBE2D3 Activates SHP-2 Ubiquitination to Promote Glycolysis and Proliferation of Glioma via Regulating STAT3 Signaling Pathway
Glioma is a primary brain cancer with high malignancy and morbidity. Current management for glioma cannot reach optimal remission. Therefore, it is necessary to find novel targets for glioma treatment. Ubiquitin-conjugating enzyme E2 D3 (UBE2D3) is involved in the pathogenesis of various kinds of ca...
Autores principales: | Pan, Zhenjiang, Bao, Jing, Zhang, Liujun, Wei, Shepeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236812/ https://www.ncbi.nlm.nih.gov/pubmed/34195079 http://dx.doi.org/10.3389/fonc.2021.674286 |
Ejemplares similares
-
UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma
por: Xu, Nuo, et al.
Publicado: (2022) -
Identification and validation of a novel ubiquitination-related gene UBE2T in Ewing’s sarcoma
por: Qu, Guoxin, et al.
Publicado: (2023) -
Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation
por: Lu, Liang, et al.
Publicado: (2017) -
Shp2 Inhibits Proliferation of Esophageal Squamous Cell Cancer via Dephosphorylation of Stat3
por: Qi, Chen, et al.
Publicado: (2017) -
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
por: Hu, Li, et al.
Publicado: (2021)